Govt Job for M.Pharm as Pharmacopoeial Associate at IPC

Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India.

IPC is created to set standards of drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region.

It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia.

It further promotes rational use of generic medicines by publishing National Formulary of India.

Post : Pharmacopoeial Associate

A Walk in Interview is going to be held at Indian Pharmacopoeia Commission (IPC) for the engagement of scientific manpower purely on contract basis through Manpower Resource Outsourcing Services Providing Agency.

Salary :32,000 per month

No. of Posts : 02

Qualification : Masters degree in Pharmacognosy, Phytochemistry/ Pharmaceutical Chemistry/ Pharmaceutical Analysis or other equivalent Post Graduation. Good knowledge of computers

Period of engagement :The tenure of contract will be for period of one year. However, in case the work and conduct of the staff is not found to be satisfactory during the contract tenure, the services may be terminated at any time without assigning any reason thereof.

General Instructions
The competent authority reserves the right to increase or decrease the number of vacancies and reject/select/cancellation of the post without
assigning any reason.

1. No TA/DA shall be paid for attending the interview. Preference may be given to the candidates who have desirable experience.
2. Experience may be relaxed at discretion of the Competent Authority
3. Please note wearing a mask and aarogyasetu app on your mobile is mandatory .

Date & Time of Interview (Reporting time: 9 am) : 20th September 2021

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre